|
|
A comparison of interventions to teach melanoma patients' skin self-examination
|
5R01CA154908-02
|
$573,751
|
$573,751
|
ROBINSON, JUNE
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
A new approach to identify rare genetic variants influencing melanoma risk
|
1R03CA156624-01A1
|
$57,600
|
$57,600
|
Lesueur, Fabienne
|
INTERNATIONAL AGENCY FOR RES ON CANCER
|
|
|
A novel preclinical model of spontaneous metastasis
|
ZIABC011167
|
$290,312
|
$275,797
|
Merlino, Glenn
|
CCR (NCI)
|
|
|
A Patient Oriented Research Program for Surgical Oncologists
|
5K24CA138709-03
|
$116,209
|
$116,209
|
GOYDOS, JAMES
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
|
A program of immune-based treatments for cancer
|
5K24CA093670-10
|
$182,272
|
$91,136
|
CARSON, WILLIAM
|
OHIO STATE UNIVERSITY
|
|
|
A role for c-Abl/Arg in melanoma progression
|
1R01CA166499-01A1
|
$315,543
|
$315,543
|
PLATTNER, RINA
|
UNIVERSITY OF KENTUCKY
|
|
|
A10Tg mice, a model of MDSC development and function in a tumor free environment
|
5F31CA159877-02
|
$33,310
|
$33,310
|
Saleem, Sheinei
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
aAPC-Mediated NKT cell Modulation to Enhance Cancer Immunotherapy
|
5K01CA131487-05
|
$99,730
|
$99,730
|
Webb, Tonya
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-36
|
$7,725,062
|
$231,752
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Accuracy in the Diagnosis of Melanoma & the Impact of Technology & Double Reading
|
5R01CA151306-02
|
$845,825
|
$845,825
|
ELMORE, JOANN
|
UNIVERSITY OF WASHINGTON
|
|
|
ACOSOG Community Clinical Oncology Program (CCOP) Research Base
|
5U10CA149950-02
|
$1,474,780
|
$14,748
|
Sloan, Jeff
|
MAYO CLINIC
|
|
|
Activation of Plasmacytoid Dendritic Cells (pDCs) to Induce Antitumor Activity
|
5P01CA128913-05
|
$1,898,043
|
$1,404,552
|
HWU, PATRICK
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Addressing Undruggable Targets Using Oligonucleotides and Small Molecules (PQ18)
|
1R21CA170332-01
|
$165,300
|
$165,300
|
JULIANO, RUDOLPH
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
|
Adoptive Cell Transfer Immunotherapy of Cancer
|
ZIABC010984
|
$1,556,987
|
$1,401,289
|
Rosenberg, Steven
|
CCR (NCI)
|
|
|
Adoptive T cell Therapy of Melanoma Targeting NY-ESO-1
|
5R01CA104711-08
|
$373,963
|
$373,963
|
YEE, CASSIAN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Akt3 Signaling as a Therapeutic Target
|
5R01CA127892-05
|
$303,925
|
$303,925
|
ROBERTSON, GAVIN
|
PENNSYLVANIA STATE UNIVERSITY
|
|
|
An Appearance-Based Intervention to Reduce Teen Skin Cancer Risk
|
3R01CA134891-03S1
|
$60,146
|
$30,073
|
HILLHOUSE, JOEL
|
EAST TENNESSEE STATE UNIVERSITY
|
|
|
An Appearance-Based Intervention to Reduce Teen Skin Cancer Risk
|
5R01CA134891-03
|
$551,100
|
$275,550
|
HILLHOUSE, JOEL
|
EAST TENNESSEE STATE UNIVERSITY
|
|
|
An innovative, curriculum-based integrated sun exposure behavior intervention for
|
1R01CA158407-01A1
|
$619,531
|
$619,531
|
COCKBURN, MYLES
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
Analysis of cap-dependent translational repression by microRNAs in oncogensis
|
5R01CA140986-02
|
$326,813
|
$326,813
|
NOVINA, CARL
|
DANA-FARBER CANCER INSTITUTE
|
|
|
Analysis of Lag-3 in Regulatory T Cell Function and Immune Supression
|
5R01CA127153-05
|
$330,091
|
$165,046
|
DRAKE, CHARLES
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Analysis of the Signaling and Mechanical Cues Promoting Invasion in Melanoma
|
5U01CA155758-02
|
$400,424
|
$400,424
|
LEVCHENKO, Andre
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Analyzing the Efficacy of Galectin-1 Ligand Inhibition in Adoptive T cell Therapy
|
1F31CA171520-01
|
$42,232
|
$42,232
|
Geddes, Jenna
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
|
|
Animal Model and Genotyping Core Support Facility
|
ZICBC011047
|
$1,205,211
|
$361,563
|
DuBois, Wendy
|
CCR (NCI)
|
|
|
Anti-melanoma Activity of Combined Lymphopenia and Immunotherapy
|
5R00CA128825-05
|
$241,530
|
$241,530
|
Pilon-Thomas, Shari
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
|
Anticancer Strategies Targeting the Autotaxin-LPA Receptor Axis
|
2R01CA092160-11
|
$302,203
|
$99,727
|
TIGYI, GABOR
|
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
|
|
|
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
|
ZIASC004020
|
$2,441,667
|
$488,333
|
Berzofsky, Jay
|
CCR (NCI)
|
|
|
Antigenic Determinants on HLA-B7 and -A2
|
5R01CA134060-28
|
$559,343
|
$559,343
|
ENGELHARD, VICTOR
|
UNIVERSITY OF VIRGINIA
|
|
|
Antitumor Mechanisms of anti-CD40/CpG-activated Macrophages
|
5R01CA087025-09
|
$261,901
|
$261,901
|
SONDEL, PAUL
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
Arginase Production in Cancer: Evading Immune Response
|
5R01CA107974-07
|
$294,654
|
$58,931
|
OCHOA, AUGUSTO
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-34S1
|
$75,000
|
$3,000
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-34S2
|
$143,846
|
$5,754
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
5P30CA023074-34
|
$3,953,813
|
$158,153
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
|
Asymmetric Division and Self Renewal of Cancer Stem Cells
|
ZIABC011003
|
$103,265
|
$7,229
|
Avital, Itzhak
|
CCR (NCI)
|
|
|
ATF2 in melanoma development and progression
|
5R01CA099961-09
|
$411,021
|
$411,021
|
RONAI, ZE'EV
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
|
|
Atlanta Regional Community Clinical Oncology Program (ARCCOP)
|
5U10CA045450-26
|
$562,599
|
$5,626
|
SEAY, THOMAS
|
ST. JOSEPH'S HOSPITAL
|
|
|
Augmenting Melanoma Response to B-Raf V600E Targeting
|
5K22CA151638-03
|
$186,840
|
$186,840
|
LO, ROGER
|
UNIVERSITY OF CALIFORNIA AT LOS ANGELES
|
|
|
B-RAF Regulation of the Cell Cycle in Melanoma
|
5R01CA125103-06
|
$248,776
|
$248,776
|
Aplin, Andrew
|
THOMAS JEFFERSON UNIVERSITY
|
|
|
B7-H1 Signaling in Ovarian Cancer
|
1R01CA164122-01A1
|
$310,040
|
$124,016
|
Curiel, Tyler
|
UNIV OF TX HSC, SA
|
|
|
B7-H1/PD-1 modulation in cancer therapy
|
5R01CA142779-03
|
$471,842
|
$155,708
|
PARDOLL, DREW
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research
|
ZIGBC010856
|
$14,609,987
|
$730,499
|
Custer, Mary
|
CCR (NCI)
|
|
|
Bay Area Tumor Institute CCOP
|
2U10CA045461-23
|
$486,165
|
$4,862
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S1
|
$41,433
|
$414
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S2
|
$75,000
|
$750
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-06
|
$2,934,758
|
$29,348
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Beaumont Community Clinical Oncology Program
|
3U10CA095860-11S1
|
$140,000
|
$1,400
|
Robertson, John
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
|
Beaumont Community Clinical Oncology Program
|
5U10CA095860-11
|
$771,835
|
$7,718
|
Robertson, John
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
|
Biochemistry of Melanins and Photoprotection of the Skin
|
ZIABC010784
|
$303,438
|
$303,438
|
Hearing, Vincent
|
CCR (NCI)
|
|
|
Biological Implications and Translational Applications of HDMX Inhibition
|
ZIABC011261
|
$205,007
|
$82,003
|
Bernal, Federico
|
CCR (NCI)
|
|
|
Biology of Melanoma Metastasis
|
5R01CA047159-21
|
$305,670
|
$305,670
|
HERLYN, MEENHARD
|
WISTAR INSTITUTE
|
|
Total relevant funding to Melanoma for this search: $121,196,691
|
